We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+7.09%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.8B
AUM Growth
+$1.26B
(+2.4%)
Cap. Flow
-$756M
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
12.51%
Holding
2,394
New
190
Increased
762
Reduced
1,027
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$173M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$143M |
| 3 |
Blue Owl Capital
OWL
|
+$142M |
| 4 |
Conagra Brands
CAG
|
+$136M |
| 5 |
Lockheed Martin
LMT
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$215M |
| 2 |
PepsiCo
PEP
|
+$200M |
| 3 |
IBM
IBM
|
+$181M |
| 4 |
Merck
MRK
|
+$123M |
| 5 |
TSMC
TSM
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.62% |
| 2 | Technology | 19.5% |
| 3 | Financials | 11.8% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Equifax
EFX
$19.2B
| $510K | ﹤0.01% |
1,743
+635
| +57% | +$177K |
|
|
TSE
1477
DELISTED
Trinseo
TSE
| $508K | ﹤0.01% |
9,688
-89,567
| -90% | -$4.85M |
|
1478
Precision BioSciences
DTIL
$183M
| $507K | ﹤0.01% |
2,280
+937
| +70% | +$262K |
|
|
GIFI
1479
DELISTED
Gulf Island Fabrication
GIFI
| $504K | ﹤0.01% |
125,616
| – | – |
|
|
CNVY
1480
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $501K | ﹤0.01% |
60,000
-6,666
| -10% | -$48.9K |
|
|
CBIO
1481
Crescent Biopharma
CBIO
$638M
| $497K | ﹤0.01% |
3,455
+9
| +0.3% | +$1.63K |
|
|
TBHC
1482
DELISTED
The Brand House Collective
TBHC
| $497K | ﹤0.01% |
33,269
+64
| +0.2% | +$1.32K |
|
1483
Lands' End
LE
$304M
| $494K | ﹤0.01% |
25,189
+16,713
| +197% | +$388K |
|
1484
Northrop Grumman
NOC
$75.4B
| $494K | ﹤0.01% |
1,276
-1,014
| -44% | -$378K |
|
1485
Pliant Therapeutics
PLRX
$66.3M
| $494K | ﹤0.01% |
+36,618
| New | +$582K |
|
1486
Amkor Technology
AMKR
$11.5B
| $493K | ﹤0.01% |
19,922
-3,542
| -15% | -$82.4K |
|
1487
MSC Industrial Direct
MSM
$6.73B
| $492K | ﹤0.01% |
5,854
-2,736
| -32% | -$229K |
|
1488
Smith & Wesson
SWBI
$586M
| $492K | ﹤0.01% |
27,659
-3,212
| -10% | -$66.3K |
|
1489
Trinity Industries
TRN
$2.26B
| $489K | ﹤0.01% |
16,208
+8,732
| +117% | +$249K |
|
1490
Powell Industries
POWL
$6.47B
| $486K | ﹤0.01% |
49,416
-46,230
| -48% | -$415K |
|
1491
APA Corp
APA
$15.7B
| $482K | ﹤0.01% |
17,908
+2,342
| +15% | +$62.2K |
|
1492
Belden
BDC
$4.4B
| $480K | ﹤0.01% |
7,296
-212
| -3% | -$13.3K |
|
1493
Tenable Holdings
TENB
$4.01B
| $474K | ﹤0.01% |
+8,609
| New | +$446K |
|
1494
Rithm Capital
RITM
$5.29B
| $471K | ﹤0.01% |
44,000
| – | – |
|
1495
Minerals Technologies
MTX
$2.15B
| $468K | ﹤0.01% |
6,396
+818
| +15% | +$58.8K |
|
1496
Provident Financial
PROV
$115M
| $467K | ﹤0.01% |
28,225
-7,282
| -21% | -$122K |
|
1497
NewMarket
NEU
$8.2B
| $464K | ﹤0.01% |
1,354
-105
| -7% | -$36.2K |
|
|
SNCR
1498
DELISTED
Synchronoss Technologies
SNCR
| $459K | ﹤0.01% |
20,901
| – | – |
|
1499
Scholar Rock
SRRK
$6.01B
| $458K | ﹤0.01% |
18,455
-306,545
| -94% | -$8.46M |
|
|
CODX
1500
Co-Diagnostics
CODX
$6.57M
| $457K | ﹤0.01% |
1,706
-654
| -28% | -$172K |
|
Similar funds
Federated Hermes's Q4 2021 Portfolio in Review
As of Q4 2021, Federated Hermes held 2,394 positions worth $53.8B, up 2.4% from $52.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q4 2021 filing shows 190 new, 762 increased, 1,027 reduced and 198 closed positions. Its largest new stake was Conagra Brands: 4,144,058 shares worth $142M. The largest sale was Moderna, an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q4 2021 buy was Conagra Brands: 4,144,058 shares worth $142M.
- Federated Hermes added most to Bristol-Myers Squibb in Q4 2021, an estimated $173M increase.
- Federated Hermes's biggest Q4 2021 reduction was Moderna, cutting an estimated $215M.
- Federated Hermes fully exited GoDaddy in Q4 2021, selling an estimated $77.2M.
- Federated Hermes's ten largest holdings make up 13% of its $53.8B portfolio in Q4 2021.
- Federated Hermes opened 190 new positions and closed 198 in Q4 2021.
- Federated Hermes's portfolio value rose 2.4% quarter-over-quarter to $53.8B.
Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.